Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issues:
Medicare Advantage & MA Rate Notice; Medicare/Transparency; Site neutral payment reform; MA Reform; Program Fraud, Waste, and Abuse; Medicaid Managed Care

Bills:
H.R.4077 - GUARD Veterans Health Care Act
To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes.
Sponsor: Rep. Doggett, Lloyd [D-TX-37]

S.2145 - GUARD Veterans Health Care Act
To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes.
Sponsor: Sen. Warren, Elizabeth [D-MA]

H.R.668 - Coordinating Care for Senior Veterans and Wounded Warriors Act
To require the Secretary of Veterans Affairs to carry out a pilot program to coordinate, navigate, and manage care and benefits for veterans enrolled in both the Medicare program and the system of annual patient enrollment of the Department of Veterans Affairs.
Sponsor: Rep. Ciscomani, Juan [R-AZ-6]

S.506 - Coordinating Care for Senior Veterans and Wounded Warriors Act
This bill requires the Department of Veterans Affairs (VA) to implement a three-year pilot program to coordinate, navigate, and manage care and benefits for veterans who are enrolled in both the Medicare program and the VA health care system.
Sponsor: Sen. Moran, Jerry [R-KS]

H.R.1227 - Alternatives to PAIN Act
To amend title XVIII of the Social Security Act to ensure appropriate access to non-opioid pain management drugs under part D of the Medicare program.
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]

H.R.9392 - Medicare Advantage Cost Transparency Act
To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data.
Sponsor: Rep. DeGette, Diana [D-CO-1]

H.R. 5243 - Supplemental Benefits Transparency Bill
To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
Sponsor: Rep. McClellan, Jennifer L. [D-VA-4]

H.R.9395 - Transparency in Medicare Advantage Steering Act
To amend title XVIII of the Social Security Act to require certain reporting with respect to agents and brokers of Medicare Advantage organizations.
Sponsor: Rep. Ocasio-Cortez, Alexandria [D-NY-14]

H.R.3514 - Improving Seniors Timely Access to Care Act of 2025
To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.
Sponsor: Rep. Kelly, Mike [R-PA-16]

H.R.8163 - Provider Reimbursement Stability Act of 2026
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
Sponsor: Rep. Murphy, Gregory F. [R-NC-3]

H.R.8883 - Protecting Seniors and Stopping Fraudsters Act
To amend title XVIII of the Social Security Act to provide for additional oversight of hospice programs and home health agencies under the Medicare program, and for other purposes.
Sponsor: Rep. Van Duyne, Beth [R-TX-24]

H.R.8871 - DME Scammer Prevention Act of 2026
To amend title XVIII of the Social Security Act to promote Medicare program integrity with respect to certain medical equipment and supplies.
Sponsor: Rep. Bean, Aaron [R-FL-4]

S.3762 - Prior Authorization Relief Act
To amend part C of title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.
Sponsor: Sen. Whitehouse, Sheldon [D-RI]

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Labor - Dept of (DOL)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Issues:
Generics access; Prescription Drug Cost; PBM Reform and Prescription Drug Policy

Bills:
S.1954 - Biosimilar Red Tape Elimination Act
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Sponsor: Sen. Lee, Mike [R-UT]

S.3014 - Ensuring Timely Access to Generics Act of 2025
To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
Sponsor: Sen. Shaheen, Jeanne [D-NH]

S.1041 - Affordable Prescriptions for Patients Act
A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]

S.1040 - Drug Competition Enhancement Act
A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]

S.1096 - Preserve Access to Affordable Generics and Biosimilars Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
Sponsor: Sen. Klobuchar, Amy [D-MN]

S.1095 - Stop STALLING Act
A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Sponsor: Sen. Klobuchar, Amy [D-MN]

S.1097 - Interagency Patent Coordination and Improvement Act of 2025
To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
Sponsor: Sen. Durbin, Richard J. [D-IL]

H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025
To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
Sponsor: Rep. Neguse, Joe [D-CO-2]

S.2658 - Medication Affordability and Patent Integrity Act
To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
Sponsor: Sen. Hassan, Margaret Wood [D-NH]

S.1302 - Increasing Transparency in Generic Drug Applications Act
To provide for increased transparency in generic drug applications.
Sponsor: Sen. Hassan, Margaret Wood [D-NH]

H.R.1843 - Increasing Transparency in Generic Drug Applications Act
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Sponsor: Rep. Dunn, Neal P. [R-FL-2]

H.R.7895 - PBM Kickback Prohibition Act
To amend section 408 of the Employee Retirement Income Security Act of 1974 to prohibit kickbacks to pharmacy benefit managers.
Sponsor: Rep. Allen, Rick W. [R-GA-12]

H.R. 6837 - PBM FAIR Act
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Sponsor: Rep. Auchincloss, Jake [D-MA-4]

H.R.3164 - Ensuring Community Access to Pharmacist Services Act
To amend title XVIII of the Social Security Act to provide pharmacy payment of certain services.
Sponsor: Rep. Smith, Adrian [R-NE-3]

S.43 - Skinny Labels, Big Savings Act
To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
Sponsor: Sen. Hickenlooper, John W. [D-CO]

H.R.6485 - Skinny Labels, Big Savings Act
To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
Sponsor: Rep. Cline, Ben [R-VA-6]

S.4189 - INSULIN Act of 2026
To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
Sponsor: Sen. Shaheen, Jeanne [D-NH]

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office, Labor - Dept of (DOL), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes